Neurocrine Biosciences

Rare Disease Therapeutics · Neurology & CNS Therapeutics
Listed: NASDAQ: NBIXHas an LEITruth index BSponsors visasDomain protected (DMARC)
78Open roles26 posted in 30 days+6 this week
$231kMedian advertised pay$179k – $257k+19% vs market
32 daysTime to fillmedian of 91 closed rolesmarket: 30 days
$2.9BRevenue, 2025net income $478.6M+21.4% a year
Lately:+6 roles posted this week8 news stories in 90 daysFollow changes →

Facts

as of Nov 16, 2026

Neurocrine Biosciences is a biopharmaceutical company headquartered in San Diego, California, that discovers, develops and commercializes treatments for neurological, psychiatric, endocrine and immunological disorders. Founded in 1992 and listed on Nasdaq, it markets medicines for tardive dyskinesia, Huntington's disease chorea and classic congenital adrenal hyperplasia, partners with AbbVie on endometriosis and uterine fibroid therapies, and runs several late-stage programs. Most openings are at the San Diego headquarters in manufacturing, quality, analytical development, regulatory strategy and IT, alongside field roles such as NeuroPsych account specialists and medical science liaisons.

It is hiring: 78 open roles, 26 of them posted in the last 30 days. Its stated pay is 19% above the market estimate for the same roles.

Headquarters
San Diego, United States
Founded
1992
Employees
1001-5000estimated range
Revenue
$2.9B2025 · SEC
Listing
NASDAQ: NBIX
Open roles
78 in 4 citiesAlion job postings
Website
neurocrine.com

As of Nov 16, 2026, Alion lists 78 open roles at Neurocrine Biosciences. Neurocrine Biosciences is headquartered in San Diego, United States. It was founded in 1992. The median pay stated in its open roles is $223k, across 64 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Postings are real
Alion truth index: B
83/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Domain and mail securityneurocrine.com · Nov 16, 2026
Spoofed mail (DMARC)
Spoofed mail goes to spam
Good
Who may send its mail (SPF)
Other senders soft-fail (~all)
Good
HTTPS certificate
Valid certificate · Let's Encrypt
Good
HTTPS enforced (HSTS)
Enforced
Good
Security contact (security.txt)
No security.txt
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy
Weak
Signed DNS (DNSSEC)
Not signed
Weak
Certificate issuers (CAA)
Any authority may issue certificates
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Hiring steadily, with new roles every week.

Science & Research is the largest family, 29 of open roles.

26Posted in 30 days33% of open roles are fresh
38%Remote roles30 of 79
1Roles in AI1% of open roles
4Hiring offices
Can they hire you from United States?by your location
Likely
150 open roles are in your country: you apply locally, no move needed.
United States150On site
Switzerland4On site
United Kingdom2On site
Remote, from elsewhere30Possible
No posting offers visa sponsorship. Remote roles: 30.
Time to fillmedian days to close a role
Neurocrine Biosciences32 days
Market, same roles30 days
Alion signals0-100
Demand95
Pay60
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 28This week
Open roles a week: 151 then, 0 now
Are the postings real?
B
83 / 100Neurocrine Biosciences scores B on the Alion truth index (A is best, E worst), measured over 6 open roles re-checked against its own hiring board: 0% look like ghost listings, 67% have gone stale and 0% are the same role posted again. Its roles close in a median of 37 days.
Ghost roles0%
Gone stale67%
Reposted0%
Where the openings areshare of open roles · trend
Science & Research29
Biotech19▼
Analytics8
Legal6▼
Management5▲
Operations5▲
Newest roles
Commercial Counsel
$206k – $282k per year · In office · Full-Time · PhD · San Diego
Executive Director, Clinical Development – Immunology (MD)
$332k – $452k per year · In office · 6+ years exp · San Diego
Sr. Analyst, Field Operations
$103k – $141k per year · In office · Full-Time · Master's Degree · San Diego
Associate Scientist, Animal Care
In office · Full-Time · 4+ years exp · San Diego
What postings ask forlanguages named in open roles
English11%
Degree asked
Bachelor's Degree 52%Doctoral Degree (PhD) 24%Master's Degree 15%High School Diploma 9%
Experience asked: 8.4 years on average, in 72 postings. 66 postings state a degree.
Benefits named in postingsshare of open roles
Equity7292%
Retirement plans7292%
Continuous learning23%
Professional development11%
Growth opportunities11%
Home office11%
Contract type
Full-Time 76Contract 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Pays 19% above the market estimate for the same roles.

$231kMedianmarket estimate $184k
$179k – $257kTypical rangeUSD a year
$452kHighest paying roleExecutive Director, Clinical Development – Immunology (MD)
Pay by levelmiddle half of stated pay, median marked · dashed: market median $184k
Senior29$196k$179k – $231k
Lead6$214k$182k – $214k
Head+21$265k$238k – $348k
$0$100k$200k$300k$400k
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

United StatesUS 18 #1,097 of 8,997 sponsors
18 ▲ 80%H-1B filings in 12 months
$123kMedian offered salary
72Open roles in United States
Who they sponsor
Chemists6
Medical scientists3
Biochemists and biophysicists2
6 more occupations and the salary for eachVisa pass · 90 credits

In the register as Neurocrine Biosciences, Inc., San Diego, CA (+1 more)

Other sponsors in the same field
US Department of Labor · latest filing Jun 25, 2026

Footprint

Hiring in 4 cities in 3 countries.

4Cities
3Countries
San DiegoBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
San Diego United StatesHeadquarters66Biotech, Science & Research, Legal18%
Allschwil SwitzerlandRegional office3Biotech, Operations0%
London United KingdomNot classified2Support, Biotech0%
Chicago United StatesNot classified1Biotech0%
Source: office addresses in postings and company registers

Ranked #7 by open roles among its 11 closest peers.

#CompanyHQOpen rolesSize
1Takeda PharmaceuticalTokyo, Japan1,1685000+
2AbbVieNorth Chicago, United States1,1545000+
3Vertex PharmaceuticalsBoston, United States2335000+
4BiogenCambridge, United States1795000+
5IpsenParis, France1631001-5000
6AlnylamCambridge, United States931001-5000
7Neurocrine BiosciencesSan Diego, United States781001-5000
8BridgeBio PharmaPalo Alto, United States721001-5000
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)

Financials

Revenue of $2.9B in 2025. +21.4% on the year before. Net income $478.6M.

$2.9BRevenue2025 · +21.4%
$478.6MNet income2025 · +40.2%
Revenue by yearas filed, with the net income
2025$2.9Bnet income $478.6M
2024$2.4Bnet income $341.3M
2023$1.9Bnet income $249.7M
2022$1.5Bnet income $154.5M
2021$1.1Bnet income $89.6M
2020$1Bnet income $407.3M
2019$788.1Mnet income $37M
2018$451.2Mnet income $21.1M
Sources: SEC

Technologies named in job postings at Neurocrine Biosciences over the last 12 months, by layer, with the share of postings for each.

64Technologies in use
87Postings analysed
65/100Stack modernityAI adopter
Sign in to see how your skills match this stackSign In
Full Neurocrine Biosciences tech stack64 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Nov 2026
Went public NASDAQ: NBIX
1992
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

#427,499Web rankTranco top 1M
Sep 292026
News · MM+M - Medical Marketing and Media
Spectrum Science previously provided PR support to Neurocrine.
Sep 292026
News · RTTNews
Neurocrine Biosciences, Inc. (NBIX) announced that Eiry W. Roberts will return as Chief Medical Officer, effective immediately, succeeding Sanjay Keswani, who will depart the com…
Sep 282026
News · YahooFinance
Neurocrine Biosciences (NBIX) said late Monday that Eiry Roberts will rejoin the company
Sep 282026
News · YahooFinance
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Eiry W. Roberts, M.D., who previously served as Neurocrine
Sources: the outlets named on each headline, each story once